So if MPL gets to market like Relyvrio did, we can expect income of US$381m in its first 12 months, and peak sales of US $2.6b! With less than 500m SOI, that's a valuation of AUD $1.15 to AUD$7.84, WITHOUT even considering any PE multiples.
Pharmaust - Media & News, page-94
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $1.507K | 8.867K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 237676 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 469358 | 9 |
View Market Depth
| Last trade - 10.06am 18/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |